封面
市場調查報告書
商品編碼
1410774

人工硬腦膜市場:按細分市場劃分的規模、份額、法律法規、報銷、程序、到 2033 年的預測

Dura Substitutes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

出版日期: | 出版商: GlobalData | 英文 | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

人工硬腦膜是修復硬腦膜時用作片材或材質的補片。閉合或修復硬腦膜對於防止腦脊髓液(CSF)滲漏至關重要。

生物人工硬腦膜具有進行血管和上皮融合的能力,有助於其與天然硬腦膜整合。這種類型的替代硬腦膜的加工方式是去除所有細胞和抗原,並且不存在疾病傳播的可能性。由於這些原因,神經血管外科醫生更喜歡使用生物硬腦膜而不是合成硬腦膜。生物硬腦膜替代物具有良好的拉伸強度,使得補片植入後穩定。

該報告深入探討了全球人造硬腦膜市場,包括競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響以及區域和國家趨勢。

目錄

人工硬腦膜目前市場及競爭狀況

  • 洞察關鍵產業趨勢
  • 2015年至2033年人工硬腦膜各細分市場的市場總收入及市場前景
  • 有關數量、平均售價和市場價值的詳細數據

全球、區域和國家見解

  • 人工硬腦膜市場的SWOT分析
  • 人工硬腦膜市場的競爭動態洞察與趨勢
  • 按國家/地區劃分的醫療保健系統概覽
  • 各國報銷政策
  • 各國醫療技術法規現狀

Abstract

Dura Substitutes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Neurology Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Dura Substitutes market for the year 2020 and beyond. Dura Substitutes are patches which are used as sheet or material in repairing the dura mater. Closure or repair of dura mater is essential to prevent a Cerebrospinal Fluid (CSF) Leak.

The model considers two types of dura substitutes, biological and synthetic. Biological dura substitutes have the ability to undergo vascular and epithelial fusion which helps them to integrate with the native dura mater. This type of substitute is processed so that all cells and antigens are removed and chances of disease transmission is nil. For this reason, neurovascular surgeons prefer using biological dura substitutes over synthetic dura substitutes. The latter have good tensile strength which provides stability to the patch after implantation.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Dura Substitutes and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Dura Substitutes market revenue by segment and market outlooks from 2015-2033.
  • Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Dura Substitutes market.
  • Competitive dynamics insights and trends provided for Dura Substitutes market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Integra LifeSciences Corp, B. Braun Melsungen AG, Medtronic Plc, DePuy Synthes Inc, Regenity Biosciences, Baxter International Inc and Others

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Dura Substitutes marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Dura Substitutes market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Dura Substitutes market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Dura Substitutes market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Dura Substitutes market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable